Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2008-09-16
2008-09-16
Ton, Thaian N (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S366000, C435S372000
Reexamination Certificate
active
10193884
ABSTRACT:
This invention provides populations human cells of the cardiomyocyte lineage. The cells are obtained by causing cultures of pluripotent stem cells to differentiate in vitro, and then harvesting cells with certain phenotypic features. Differentiated cells bear cell surface and morphologic markers characteristic of cardiomyocytes, and a proportion of them undergo spontaneous periodic contraction. Highly enriched populations of cardiomyocytes and their replicating precursors can be obtained, suitable for use in a variety of applications, such as drug screening and therapy for cardiac disease.
REFERENCES:
patent: 5733727 (1998-03-01), Field
patent: 5843780 (1998-12-01), Thomson
patent: 5928943 (1999-07-01), Franz et al.
patent: 6015671 (2000-01-01), Field
patent: 6099832 (2000-08-01), Mickle et al.
patent: 6110459 (2000-08-01), Mickle et al.
patent: 6245566 (2001-06-01), Gearhart et al.
patent: 6261836 (2001-07-01), Cech et al.
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 6399300 (2002-06-01), Field
patent: 729377 (2001-02-01), None
patent: WO 92/13066 (1992-08-01), None
patent: WO 95/14079 (1995-05-01), None
patent: WO 99/49015 (1999-09-01), None
patent: WO 00/06701 (2000-02-01), None
patent: WO 00/70021 (2000-11-01), None
patent: WO 00/78119 (2000-12-01), None
patent: WO 01/22978 (2001-04-01), None
patent: WO 01/51616 (2001-07-01), None
patent: WO 01/53465 (2001-07-01), None
patent: WO 01/68814 (2001-09-01), None
patent: WO 02/09650 (2002-02-01), None
patent: WO 02/13760 (2002-02-01), None
patent: WO 02/19893 (2002-03-01), None
patent: WO 02/30206 (2002-04-01), None
Rice and Leinwand. JCB, 163(1):119-129 (2003).
Verfaillie et al. Hematology (Am Soc Hematol Educ Program). 2002;:369-91.
Strauer and Kornowski. Circulation (2003) 107:929-934.
Murray et al. Journal of Cardiac Failure (2002) 8:S532-S541.
Kamsi, Nature, Oct. 26, 2005 (online).
Antin, et al., Regulation of Avian Precardiac Mesoderm Development by Insulin and Insulin-Like growth factors, J. Cell. Physiol. 168:42(1996).
Aral, et al., Murine cardiac progenitor cells require visceral embryonic endoderm and primitive streak for terminal differentiation, Dev. Dynamics 210:344 (1997).
Barron, et al., Repuirement for BMP and FGF signaling during cardiogenic induction in non-precrdiac mesoderm is specific, translent, and cooperative, Dev. Dynamics 218:383 (2000).
Claycomb, et al., HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte, Proc. Natl. Acad. Sci. USA 95:2979 (1998).
Doevendans, et al., Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes, J. Mol Cell Cardiol. 32:839 (2000).
Fukuda, Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering, Artificial Organs 25:187 (2001).
Grepin, et al., Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor, Development 124:2387 (1997).
Gryschenko, et al., Outwards currents in embryonic stem cell-derived cardiomyocytes, Pflugers Arch. 439:798 (2000).
Itskovitz-Eldor, et al., Differentiation of Human Embronic Stem Cells into Embryoid Bodies Comprising the Three Emryonic Germ Layers, Mol. Med. 6:88 (2000).
Kehat, et al., Human embryonic stem cells can diffrentiate into cyocytes with structural and functional properties of cardiomyocytes, J. Clin. Invest. 108:407 (2001).
Kessler, et al., Myoblast cell grafting into heart muscle: Cellular Biology and Potential Applications, Annu. Rev. Physiol. 61:219 (1999).
Klug, et al., Genetically Selected Cardiomyocytes from Differentiating Embryonic Stem Cells From Stable Intracardiac Grafts, J. Clin. Invest. 98:216 (1996).
Koide, et al., Atrial natriuretic peptide accelerates proliferation of chick embryonic cardiomyocytes in vitro, Differentiation 61:1 (1996).
Kolossov, et al., Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein, J. Cell Biol. 143:2045 (1998).
Ladd, et al., Regulation of avian cardiac myogenesis by activin/TGFB and bone morphogenetic proteins, Dev. Biology 204:407 (1998).
Liechty, et al., Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep, Nature Med. 6:1282 (2000).
Li, et al., Isolation of cardiomyocytes from human myocardium for primary cell culturing, J. Tiss. Cult. Meth. 15:147 (1993).
Lough, et al., Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm, Dev. Biology 178:198 (1996).
Makino, et al., Cardiomyocytes can be generated from marrow stromal cells in vitro, J. Clin. Invest. 103:697 (1999).
Maltsev, et al., Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types, Mechanisms Dev. 44:41 (1993).
Marvin, et al., Inhibition of Wnt activity induces heart formation from posterior mesoderm, Genes Dev. 15:316 (2001).
McBurney, et al., Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line, Nature 299:165 (1982).
Min, et al., Transplantation of embryonic stem cells improves cardiac function in postinfacted rats, J. Appl. Physiol. 92:288 (2002).
Monzen, et al., Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase kinase TAK1 and cardiac transcription factors CsxNkx-2.5 and GATA-4, Mol. Cell. Biol. 19:7096 (1999).
Muller, et al., Selection of ventricular-like cardiomyocytes from ES cells in vitro, FASEB J. 14:2540 (2000).
Muslin, et al., Wll-defined growth factors promote cardiac development in axoloti mesodermal explants, Development 112:1095 (1991).
Narita, et al., Cardiomyocyte differentiation by GATA-4-deficient embryonic stem cells, Development 124:3755 (1997).
Olson, et al., Molecular pathways controlling heart development, Science 272:671 (1996).
Qin, et al., Gene transfer of transforming growth factor-B1 prolongs murine cardic allograft survival by inhibiting cell-mediated Immunity, Human Gene Therapy 7:1981 (1996).
Reubinoff, et al, Embryonic stem cell line from human blastocysts: somatic differentiation in vitro, Nature Biotech. 18:399 (2000).
Scalia, et al., Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A, J. Cell. Biochem. 82:610 (2001).
Schneider, et al., Wnt antagonism initiates cardiogenesis inXenopus laevis, Genes Dev. 15:304 (2001).
Schuldiner, et al., Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells, PNAS 97:11307 (2000).
Schultheiss, et al., A role for bone morphogenetic proteins in the induction of cardiac myogenesis, Genes & Dev. 11:451 (1997).
Shamblott, et al., Derivation of pluripotent stem cells from cultured human primordial germ cells, Proc. Natl. Acad. Sci. USA 95:13726 (1998).
Shi, et al., BMP signaling is required for heart formation in vertebrates, Dev. Biol. 224:226 (2000).
Skerjane, et al., Myocyte enhanncer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomygenesis in P19 cells, J. Biol. Chem. 273:34904 (1998).
Sugi, et al., Activin-A and FGF-2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro, Dev. Biology 168:567 (1995).
Thomson, et al., Embryonic stem cell lines derived from human blastocytes, Science 282:1145 (1998).
Velez, et al., Modulationo f contractile protein troponin-T in chick myocardial cells by basic fibroblast growth factor and platelet-derived growth factor during development, J. Cardiovascular Pharmacology 24:906 (1994).
Volz, et al., Longevity of adult ventricular rat heart muscle cells in serum-free primary culture, J. Mol. Cll Cardiol. 23:161 (1991).
Wobus, et al., In vitro cellular models for cardiac development and pharmacotoxicolgy, Toxic. in Vitro 9:477 (1995).
Wobus, et al., Development of cardiomyocytes expressing cardiac-specific genes, action potentials, and
Geron Corporation
Law Office of Salvatore Arrigo
Ton Thaian N
LandOfFree
Cardiomyocyte precursors from human embryonic stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiomyocyte precursors from human embryonic stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiomyocyte precursors from human embryonic stem cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3914666